13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001600004
申报总市值
US$16.5亿
US$16.5亿
38 檔
20.5%
在 Q3 2024 的 13F 官方备案中，First Light Asset Management, LLC 管理的美股投资组合规模来到 US$16.5亿，整体持股档数为 38 档。
在 Q3 2024，First Light Asset Management, LLC 展现出较为审慎的避险与获利了结姿态。本季共减仓 19 个仓位并完全清仓 11 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，First Light Asset Management, LLC 的前 5 大核心持股（包含 260, FNAUSD, EVH 等）合计占整体申报市值的 20.5%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 7.90% | -5.56% | EXIT | |
| 2 | FNAUSD | Paragon 28 Inc | 股票-其他 | 5.64% | — | +24.22% | |
| 3 | EVH | Evolent Health Inc - A | 股票-其他 | 5.41% | — | +59.02% | |
| 4 | AXGN | Axogen Inc | 股票-其他 | 4.77% | -4.16% | +22.32% | |
| 5 | ATRC | Atricure Inc | 股票-其他 | 4.35% | -0.90% | -5.05% | |
| 6 | INSM | Insmed Inc | 股票-医疗保健 | 4.18% | — | +24.96% | |
| 7 | CRNX | Crinetics Pharmaceuticals In | 股票-其他 | 4.01% | -0.45% | -21.40% | |
| 8 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 3.87% | — | -9.54% | |
| 9 | NEO | Neogenomics Inc | 股票-医疗保健 | 3.78% | +4.42% | -18.66% | |
| 10 | DYN | Dyne Therapeutics Inc | 股票-其他 | 3.76% | — | +228.76% | |
| 11 | TNDM | Tandem Diabetes Care Inc | 股票-其他 | 3.62% | +0.84% | +44.72% | |
| 12 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 3.49% | — | -21.60% | |
| 13 | PFMTUSD | Performant Financial CORP | 股票-其他 | 3.49% | — | +6.62% | |
| 14 | TMDX | Transmedics Group Inc | 股票-医疗保健 | 3.47% | — | -11.60% | |
| 15 | OSCR | Oscar Health Inc - Class A | 股票-医疗保健 | 3.12% | — | -5.36% | |
| 16 | PODD | Insulet CORP | 股票-医疗保健 | 3.08% | — | -26.23% | |
| 17 | HCAT | Health Catalyst Inc | 股票-其他 | 2.91% | +0.08% | +8.60% | |
| 18 | ANAB | Anaptysbio Inc | 股票-其他 | 2.64% | -0.42% | +21.69% | |
| 19 | PPHMEUR | Avid Bioservices Inc | 股票-其他 | 2.62% | — | — | |
| 20 | VERA | Vera Therapeutics Inc | 股票-其他 | 2.59% | -1.13% | EXIT | |
| 21 | PLRX | Pliant Therapeutics Inc | 股票-其他 | 2.40% | — | -24.28% | |
| 22 | RGEN | Repligen CORP | 股票-医疗保健 | 2.05% | — | — | |
| 23 | NTRA | Natera Inc | 股票-医疗保健 | 1.95% | — | -49.89% | |
| 24 | GPCR | Structure Therapeutics Inc | 股票-其他 | 1.85% | — | -14.29% | |
| 25 | BCYC | Bicycle Therapeutics Plc-adr | 股票-其他 | 1.82% | — | -30.17% | |
| 26 | SIBN | Si-bone Inc | 股票-其他 | 1.78% | +2.00% | -38.29% | |
| 27 | KYMR | Kymera Therapeutics Inc | 股票-其他 | 1.60% | — | — | |
| 28 | KRMD | Koru Medical Systems Inc | 股票-其他 | 1.27% | -0.60% | +11.13% | |
| 29 | GH | Guardant Health Inc | 股票-医疗保健 | 1.24% | +1.71% | +55.65% | |
| 30 | OPRX | Optimizerx CORP | 股票-其他 | 1.16% | — | -0.84% | |
| 31 | RLAY | Relay Therapeutics Inc | 股票-其他 | 0.91% | — | — | |
| 32 | AVTR | Avantor Inc | 股票-医疗保健 | 0.77% | — | -39.75% | |
| 33 | MOH | Molina Healthcare Inc | 股票-医疗保健 | 0.76% | — | — | |
| 34 | ASND | Ascendis Pharma A/S | 股票-其他 | 0.64% | — | +43.05% | |
| 35 | NARIUSD | Inari Medical Inc | 股票-其他 | 0.60% | — | -63.04% | |
| 36 | EXK | Exact Sciences CORP | 股票-原材料 | 0.39% | — | -44.61% | |
| 37 | ATEC | Alphatec Holdings Inc | 股票-其他 | 0.06% | — | -97.41% | |
| 38 | ✓ | 股票-其他 | 0.02% | — | +14.44% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | 260 | Centessa Pharmaceuticals-adr | +4.1% | +24.26% | 加仓 |
| 2 | EVH | Evolent Health Inc - A | +3% | +59.02% | 加仓 |
| 3 | AXGN | Axogen Inc | +2.7% | +22.32% | 加仓 |
| 4 | PPHMEUR | Avid Bioservices Inc | +2.6% | NEW | 新建仓 |
| 5 | DYN | Dyne Therapeutics Inc | +2.6% | +228.76% | 加仓 |
| 6 | RGEN | Repligen CORP | +2.1% | NEW | 新建仓 |
| 7 | KYMR | Kymera Therapeutics Inc | +1.6% | NEW | 新建仓 |
| 8 | TNDM | Tandem Diabetes Care Inc | +1.1% | +44.72% | 加仓 |
| 9 | INSM | Insmed Inc | +0.9% | +24.96% | 加仓 |
| 10 | ANAB | Anaptysbio Inc | +0.9% | +21.69% | 加仓 |
| 11 | RLAY | Relay Therapeutics Inc | +0.9% | NEW | 新建仓 |
| 12 | PFMTUSD | Performant Financial CORP | +0.8% | +6.62% | 加仓 |
| 13 | MOH | Molina Healthcare Inc | +0.8% | NEW | 新建仓 |
| 14 | FNAUSD | Paragon 28 Inc | +0.7% | +24.22% | 加仓 |
| 15 | HCAT | Health Catalyst Inc | +0.7% | +8.60% | 加仓 |
| 16 | OSCR | Oscar Health Inc - Class A | +0.5% | -5.36% | 减仓 |
| 17 | ATRC | Atricure Inc | +0.4% | -5.05% | 减仓 |
| 18 | ASND | Ascendis Pharma A/S | +0.2% | +43.05% | 加仓 |
| 19 | GH | Guardant Health Inc | +0.2% | +55.65% | 加仓 |
| 20 | KRMD | Koru Medical Systems Inc | +0.1% | +11.13% | 加仓 |
| 21 | RARE | Ultragenyx Pharmaceutical In | 0% | -21.60% | 减仓 |
| 22 | ✓ | 0% | +14.44% | 加仓 | |
| 23 | EXK | Exact Sciences CORP | -0.1% | -44.61% | 减仓 |
| 24 | SLP | Simulations Plus Inc | -0.1% | EXIT | 清仓 |
| 25 | GPCR | Structure Therapeutics Inc | -0.2% | -14.29% | 减仓 |
| 26 | INSP | Inspire Medical Systems Inc | -0.3% | EXIT | 清仓 |
| 27 | AVTR | Avantor Inc | -0.3% | -39.75% | 减仓 |
| 28 | STVN | Stevanato Group S.p.A. | -0.4% | EXIT | 清仓 |
| 29 | OPRX | Optimizerx CORP | -0.4% | -0.84% | 减仓 |
| 30 | TMDX | Transmedics Group Inc | -0.5% | -11.60% | 减仓 |
| 31 | CNC | Centene CORP | -0.5% | EXIT | 清仓 |
| 32 | HUM | Humana Inc | -0.5% | EXIT | 清仓 |
| 33 | XENE | Xenon Pharmaceuticals Inc | -0.6% | -9.54% | 减仓 |
| 34 | VERA | Vera Therapeutics Inc | -0.6% | -29.88% | 减仓 |
| 35 | BCYC | Bicycle Therapeutics Plc-adr | -0.6% | -30.17% | 减仓 |
| 36 | PEN | Penumbra Inc | -0.7% | EXIT | 清仓 |
| 37 | CRNX | Crinetics Pharmaceuticals In | -0.7% | -21.40% | 减仓 |
| 38 | SVRA | Savara Inc | -0.7% | EXIT | 清仓 |
| 39 | PODD | Insulet CORP | -0.7% | -26.23% | 减仓 |
| 40 | PLRX | Pliant Therapeutics Inc | -0.8% | -24.28% | 减仓 |
| 41 | NEO | Neogenomics Inc | -0.8% | -18.66% | 减仓 |
| 42 | PCVX | Vaxcyte Inc | -0.9% | EXIT | 清仓 |
| 43 | SIBN | Si-bone Inc | -1% | -38.29% | 减仓 |
| 44 | NARIUSD | Inari Medical Inc | -1.4% | -63.04% | 减仓 |
| 45 | TCMD | Tactile Systems Technology I | -1.4% | EXIT | 清仓 |
| 46 | NTRA | Natera Inc | -1.6% | -49.89% | 减仓 |
| 47 | RCM1USD | R1 Rcm Inc | -2.7% | EXIT | 清仓 |
| 48 | LIVN | LivaNova PLC | -3.4% | EXIT | 清仓 |
| 49 | ATEC | Alphatec Holdings Inc | -4.8% | -97.41% | 减仓 |
根据 SEC 官方 Form 13F 申报备案，First Light Asset Management, LLC 在 Q3 2024 季度的美股持仓总市值约为 US$16.5亿，共申报了 38 个公开持股仓位。
在 Q3 2024 季度，First Light Asset Management, LLC 按市值排列的前三大核心持股分别为：260 (7.9%)、FNAUSD (5.6%)、EVH (5.4%)。其中最大持股仓位 260 占据整体投资组合约 7.9% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
PPHMEUR
市值: US$3154.4万
本季最大获利了结 / 清仓标的
LIVN
前期市值: US$3894.4万
在 Q3 2024 季度中，First Light Asset Management, LLC 共进行了 49 项持仓异动，包含新建仓 5 个仓位、加仓 14 个仓位、减仓 19 个仓位以及清仓 11 个仓位。 其中最大新建仓标的为 PPHMEUR。 本季清仓仓位包含 LIVN。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。